Highlights
A collection of news and information related to Enbrel (drug) published by this site and its partners.
Displaying items 1-9 of 9
» View baltimoresun.com items only
-
Números fascinantes --y decepcionantes-- en las Grandes Ligas
Robinson Cano, un pelotero que parece hacerlo todo en cámara lenta, tuvo un mal día la semana pasada ante los Angelinos de Los Angeles.
El segunda base dominicano de los Yankees de Nueva York se fue en blanco en cinco turnos y se ponchó dos veces con las...Tags: Tim Salmon, Andy Lee, Orange Bowl, Curb Your Enthusiasm (tv program), Johnny Bench
-
UPDATE 2-FDA staff question Pfizer arthritis drug benefits
Reuters* Tofacitinib meant to treat rheumatoid arthritis * FDA staff question benefits, say drug tied to cancerous cells * FDA advisory committee to vote on drug on Wednesday * Pfizer shares rise 0.5 pct (Adds competitors, shares, details on drug, analyst...Tags: X-rays, Drugs and Medicines, John Wallace, Pneumonia, Johnson & Johnson Inc.
-
UPDATE 1-U.S. FDA advisers back Pfizer arthritis drug
Reuters(Adds shares price, panel comment, details on competitors, disease) WASHINGTON, May 9 (Reuters) - Pfizer Inc won a U.S. advisory panel's support on Wednesday for its arthritis drug, which the world's largest drugmaker hopes will give a significant...Tags: Drugs and Medicines, Johnson & Johnson Inc., Viagra (drug), Food and Drug Administration, Amgen Inc.
-
UPDATE 2-U.S. FDA advisers back Pfizer arthritis drug
Reuters* Tofacitinib meant to treat rheumatoid arthritis * Drug likely to be used as third option * Shares up 1.1 pct (Changes dateline (previously Washington); adds company comment, details on side effects; updates shares) By Anna Yukhananov SILVER SPRING,...Tags: Drugs and Medicines, Pneumonia, Johnson & Johnson Inc., Viagra (drug), Food and Drug Administration
-
PREVIEW-US panel seen backing Pfizer's arthritis drug hope
Reuters* FDA advisors to review the drug on Wednesday * Safety concerns will be a focus * Analysts peg chance for FDA approval as high as 85 pct * Tofacitinib could eventually challenge Abbott's Humira By Anna Yukhananov WASHINGTON, May 3 (Reuters) - Pfizer...Tags: Johnson & Johnson Inc., Psoriasis, Arthritis, Bones and Joints, Symptoms
-
Amgen's first-quarter profit rises 5%
Biotech giant Amgen Inc. reported a 5% increase in first-quarter profit, lifted by solid sales overall that helped offset continued weakness for its anemia treatments.
The Thousand Oaks company reported profit of $1.18 billion, or $1.48 a share, for...Tags: Earnings Forecasts, Health Treatments, Amgen Inc., Psoriasis, Anemia
-
|Story
-
|Story
-
|Story
May 31, 2012
|Column| South Florida Sun-Sentinel
May 7, 2012
|Story| Reuters
May 9, 2012
|Story| Reuters
May 9, 2012
|Story| Reuters
May 3, 2012
|Story| Reuters
Apr 25, 2012
|Story| Los Angeles Times
Jan 31, 2012
|Story| Associated Press
Jan 31, 2012
|Story| Associated Press
Jan 31, 2012
|Story| Reuters
Original site for Enbrel (drug) topic gallery.
